UroGen Pharma URGN
NASDAQ URGN
$40.80 +0.35 (+0.87%)
As of: Sep 30, 2026 · 1:02 PM EDT

UroGen Pharma Ltd. (URGN) Common Equity (2016 - 2026)

Updated

UroGen Pharma's Common Equity was -$132.4 million in Q2 2026, compared with -$93.38 million a year earlier.

Analysis

UroGen Pharma Ltd. (URGN) Common Equity (2016 - 2026) Analysis & Trends

At the end of FY2025, Common Equity at UroGen Pharma came in at -$105.47 million.

  • In earlier years, Common Equity was -$8.8 million in FY2024, -$65.21 million in FY2023, -$89.36 million in FY2022 and $8.41 million in FY2021 (-91.3%).
  • The Q2 2026 figure marks the lowest quarterly Common Equity since Q2 2023.
  • Per Business Quant data, URGN's Common Equity in the three quarters before Q2 2026 was -$124.25 million (Q1 2026), -$105.47 million (Q4 2025) and -$115.41 million (Q3 2025).
Peer Set

Peer Comparison

Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -132.40 Mn
Mar 31, 2026 -124.25 Mn
Dec 31, 2025 -105.47 Mn
Sep 30, 2025 -115.41 Mn
Jun 30, 2025 -93.38 Mn
Mar 31, 2025 -46.46 Mn
Dec 31, 2024 -8.80 Mn
Sep 30, 2024 25.52 Mn
Jun 30, 2024 30.31 Mn
Mar 31, 2024 -40.13 Mn
Dec 31, 2023 -65.21 Mn
Sep 30, 2023 -41.99 Mn
Jun 30, 2023 -138.43 Mn
Mar 31, 2023 -116.55 Mn
Dec 31, 2022 -89.36 Mn
Sep 30, 2022 -63.29 Mn
Jun 30, 2022 -40.91 Mn
Mar 31, 2022 -17.07 Mn
Dec 31, 2021 8.41 Mn
Sep 30, 2021 31.54 Mn
API Access

UroGen Pharma Ltd. Common Equity API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=common-equity&ticker=URGN&period=max&api_key=YOUR_API_KEY